Boardroom Alpha
Boardroom Alpha
BWA · Current Report (Form 8-K) · Filed August 10, 2026

Borgwarner Inc — Current Report (Form 8-K)

Form
8-K
Filed
August 10, 2026
Period
Aug 10, 2026
Ticker
BWA
Accession
0000908255-26-000054
Boardroom Alpha · Filing insights

BorgWarner launches cash tender offers for select notes; offers expire August 14, 2026 as part of capital allocation.

About Borgwarner Inc
Market cap
$13.1B
1Y TSR
+65.2%
3Y TSR
+19.1%
Board grade
B-
Sector
Consumer Cyclical
CEO
Joseph F Fadool
Last annual meeting: Apr 29, 2026 · View full Borgwarner Inc profile →
bwa-20260810
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): August 10, 2026
BORGWARNER INC.
________________________________________________
(Exact name of registrant as specified in its charter)
Delaware
1-12162
13-3404508
State or other jurisdiction of
Commission File No.
(I.R.S. Employer
Incorporation or organization
 
Identification No.)
3850 Hamlin Road,
Auburn Hills,
Michigan
 
48326
(Address of principal executive offices)
 
(Zip Code)
Registrant’s telephone number, including area code: (248) 754-9200
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of
the registrant under any of the following provisions:
o
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o
o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Title of each class
Trading Symbol(s)
Name of each exchange on which
registered
Common Stock, par value $0.01 per share
BWA
New York Stock Exchange
1.00% Senior Notes due 2031
BWA31
New York Stock Exchange
                                                                                                                                           
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the
Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2
of this chapter).
Emerging growth company o  
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended
transition period for complying with any new or revised financial accounting standards provided pursuant to Section
13(a) of the Exchange Act.  o  
Item 7.01    Regulation FD Disclosures
On August 10, 2026, BorgWarner Inc. (the “Company”) issued a press release announcing the
commencement of cash tender offers (each a “Tender Offer” and collectively, the “Tender Offers”) for (i)
any and all of its outstanding 7.125% Senior Notes due 2029 and (ii) up to $720,000,000 aggregate
purchase price of the outstanding 4.375% Senior Notes due 2045, 5.400% Senior Notes due 2034,
4.950% Senior Notes due 2029, and 2.650% Senior Notes due 2027 (collectively, the “Notes”). The
complete terms of the Tender Offers are set forth in the Offer to Purchase and any related documents
(collectively, the “Tender Offer Documents”) that will be sent to the registered holders of the Notes of each
series and will be posted online at https://www.gbsc-usa.com/borgwarner.com. The Tender Offers will
expire at 5:00 p.m., New York City time, on August 14, 2026 (such time and date, as it may be extended,
the “Expiration Date”), unless extended or earlier terminated by the Company. The Company is making
the Tender Offers as a balanced capital allocation strategy intended to grow the long-term earnings of the
Company. 
A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K, which
is incorporated herein by reference.
The information contained in this Item 7.01 of this Current Report on Form 8-K, including Exhibit
99.1, is being furnished and shall not be deemed to be “filed” for the purpose of the Securities Exchange
Act of 1934, as amended, nor shall it be deemed incorporated by reference in any filing under the
Exchange Act or the Securities Act of 1933, as amended, regardless of any general incorporation
language in any such filings.
Item 9.01      Financial Statements and Exhibits
(d)  Exhibits. The following exhibits are being furnished as part of this Report.
.
Exhibit
Number
Description
99.1
104
Cover Page Interactive Data File (embedded with Inline XBRL document).
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly
caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
BorgWarner Inc.
Date: August 10, 2026
By:
/s/ Tonit M. Calaway
Name: Tonit M. Calaway
Title: Executive Vice President and Secretary
From this filing to the file

Every SEC filing, parsed structured.

Boardroom Alpha indexes every 8-K, 10-K, 10-Q, and proxy back to 2000 — vote tabulations, comp tables, red flags, insider transactions, all queryable the day they hit EDGAR.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Borgwarner Inc (BWA)

Reference

Frequently asked questions

When did Borgwarner Inc file this 8-K?
Borgwarner Inc (BWA) filed this Current Report (Form 8-K) with the SEC on August 10, 2026. The accession number assigned by EDGAR is 0000908255-26-000054.
What does an 8-K disclose?
Form 8-K is the SEC's current-report form, used to disclose material events between periodic reports (10-K / 10-Q). Triggers include CEO/CFO departures, acquisitions, bankruptcies, earnings releases, auditor changes, changes in fiscal year, and amendments to corporate governance. Each 8-K is keyed to one or more Item numbers (1.01 through 9.01).
What is the key takeaway from this filing?
BorgWarner launches cash tender offers for select notes; offers expire August 14, 2026 as part of capital allocation. This is Boardroom Alpha's one-line summary of the current report; see the full filing text above for the formal disclosure.
What Item codes does an 8-K cover?
An 8-K's Item codes (1.01 through 9.01) specify what kind of event is being disclosed — e.g. Item 1.01 for entering a material agreement, Item 5.02 for departure/election of directors and executive officers, Item 8.01 for other events. The Item codes for this 8-K appear in the filing text above.
Where can I find Borgwarner Inc's prior current reports on EDGAR?
The SEC EDGAR browser lists every 8-K Borgwarner Inc has filed under CIK 908255, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer